
### [MONDO:0004949](http://purl.obolibrary.org/obo/MONDO_0004949)
**Label:** neoplasm of mature b-cells

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large B-cell lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0005615](http://purl.obolibrary.org/obo/MONDO_0005615) (plasmacytoma), 

**Corr. equiv. classes:** [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [Orphanet:86855](http://www.orpha.net/ORDO/Orphanet_86855), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), 

**Class expressions from DL-Learner:**

- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0001743](http://purl.obolibrary.org/obo/HP_0001743) (Abnormality of the spleen) and [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 59.97%
- [HP:0001743](http://purl.obolibrary.org/obo/HP_0001743) (Abnormality of the spleen) and [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) 59.97%
- [HP:0001743](http://purl.obolibrary.org/obo/HP_0001743) (Abnormality of the spleen) and [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0002202](http://purl.obolibrary.org/obo/HP_0002202) (Pleural effusion) and [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%


